Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

94 trials

NCT07085676
Recruiting
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · Israel · 1 site
Registry update: 6 May 2026
NCT06193889
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Phase 2/3 · Australia, Brazil, Germany, United Kingdom, Saudi Arabia, United States · 22 sites
Registry update: 29 Jul 2026
NCT06502015
Recruiting
Biomarkers in Autoimmune Disease of Nervous System
Not applicable · China · 1 site
Registry update: 29 Jul 2026
NCT06064461
Recruiting
Vitaccess Real MG Registry
Not applicable · United Kingdom, United States · 8 sites
Registry update: 29 Jul 2025
2023-507539-40-00
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Phase 2 · Belgium, Denmark, Spain, France, Italy, Netherlands, Poland · 26 sites
Registry update: 11 Nov 2026
NCT06371040
Recruiting
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
Phase 1 · China · 1 site
Registry update: 15 Sept 2025
NCT06447597
Recruiting
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Phase 2/3 · China · 18 sites
Registry update: 14 Aug 2026
NCT06392386
Recruiting
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Phase 2/3 · Australia, Belgium, Canada, Switzerland, Czechia, Germany, Spain, France, United Kingdom, Israel, Italy, Netherlands, Poland, United States · 22 sites
Registry update: 28 Sept 2026
NCT06463587
Recruiting
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Canada, Switzerland, China, Czechia, Germany, Spain, France, United Kingdom, Georgia, Greece, Hungary, India, Italy, Japan, South Korea, Poland, Romania, Serbia, Sweden, Taiwan, United States · 159 sites
Registry update: 21 Oct 2026
NCT06455709
Recruiting
Markers of Favorable Response to Complement Inhibitors Therapy
Not applicable · Italy · 1 site
Registry update: 1 Aug 2025
NCT06414954
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · Belgium, Denmark, Spain, France, Georgia, Italy, Netherlands, Poland, Serbia, United States · 40 sites
Registry update: 21 Aug 2026
NCT07653984
Recruiting
Cohort Study on Neuroimmune Diseases in the Reproductive Age
Not applicable · China · 1 site
Registry update: 17 Jun 2026
NCT07136844
Recruiting
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Not applicable · Belgium · 1 site
Registry update: 22 Aug 2025
NCT06249438
Recruiting
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Phase 1 · China · 1 site
Registry update: 25 Jul 2025
NCT04535843
Recruiting
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
Not applicable · China · 4 sites
Registry update: 28 May 2025
NCT06241521
Recruiting
Myasthenia Gravis Registry in China
Not applicable · China · 16 sites
Registry update: 5 Feb 2024
NCT05564936
Recruiting
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
Not applicable · France, United States · 19 sites
Registry update: 11 Apr 2025
NCT06299748
Recruiting
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Not applicable · Germany, Spain, Italy, United States · 4 sites
Registry update: 17 Feb 2026
NCT07146425
Recruiting
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Not applicable · China · 1 site
Registry update: 28 Aug 2025
NCT06259071
Recruiting
MuSK Myasthenia 1000 Study
Not applicable · United States · 1 site
Registry update: 5 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.